Dr. Swara Afiniwala, MD

Dr. Afiniwala practices at Monmouth Medical Center in Long Branch, New Jersey, part of RWJBarnabas Health.

Dr. Afiniwala's NPI, 1760775506, was assigned on May 26, 2011. Dr. Afiniwala holds New Jersey license 25MA09565300.

Dr. Afiniwala's primary practice is Monmouth Medical Center, at 300 Second Avenue, Long Branch, NJ 07740 in Monmouth County. The practice phone is (732) 222-5200.

Dr. Afiniwala's primary practice is Monmouth Medical Center in Long Branch, New Jersey, part of RWJBarnabas Health. Dr. Afiniwala is also affiliated with Jersey Shore University Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Afiniwala to 3 more hospitals, 3 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Afiniwala practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Afiniwala's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Afiniwala is licensed in New Jersey.

CMS data shows 3,905 Medicare services from Dr. Afiniwala across 7 procedure codes in 2024, for 860 Medicare patients. Medicare paid $361,721 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 860 Medicare patients who saw Dr. Afiniwala in 2024. The largest group is 75 to 84, with 310 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Afiniwala's median patient age at 73, with 48% women.

In 2024, Dr. Afiniwala wrote 1,370 Medicare Part D claims for 342 patients. 87% of them were for generic drugs. CMS names the drug for 825 of them, across 30 drugs with 11 or more claims each, at $55,204 in total drug cost. In 2023, CMS named 385 claims across 16 drugs.

Dr. Afiniwala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 38 general payments to Dr. Afiniwala from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $158.